An efficient randomised trial design for multi-cancer screening blood tests: nested enhanced mortality outcomes of screening trial
Lancet Oncol
.
2021 Oct;22(10):1360-1362.
doi: 10.1016/S1470-2045(21)00204-7.
Authors
Allan Hackshaw
1
,
Christine D Berg
2
Affiliations
1
Cancer Research UK & UCL Cancer Trials Centre, University College London, London W1T 4TJ, UK. Electronic address: a.hackshaw@ucl.ac.uk.
2
Division of Cancer Prevention, US National Cancer Institute, Bethesda, MD, USA; medical consultant, Bethesda, MD, USA.
PMID:
34592178
DOI:
10.1016/S1470-2045(21)00204-7
No abstract available
MeSH terms
Early Detection of Cancer
Hematologic Tests
Humans
Mass Screening
Neoplasms / blood
Neoplasms / diagnosis*
Neoplasms / mortality*
Randomized Controlled Trials as Topic*
Research Design*
Grants and funding
25349/CRUK_/Cancer Research UK/United Kingdom